Kymera Therapeutics (KYMR) Shares Outstanding (Diluted) (2019 - 2026)
Kymera Therapeutics' Weighted Average Shares Outstanding (Diluted) came in at 98.18 million for Q3 2026, up 12.5% from 87.3 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Kymera Therapeutics (KYMR) Shares Outstanding (Diluted) (2019 - 2026) Analysis & Trends
For FY2025, Kymera Therapeutics' Weighted Average Shares Outstanding (Diluted) was 84.49 million, up 12.6% from FY2024.
- Weighted Average Shares Outstanding (Diluted) has increased in each of the last five years, with a five-year compound annual growth rate of 37.2% (FY2020 to FY2025).
- Going back by year, Weighted Average Shares Outstanding (Diluted) was 75.04 million in FY2024 (+28.6%), 58.37 million in FY2023 (+8.2%), 53.93 million in FY2022 (+12.4%) and 47.99 million in FY2021 (+176.6%).
- Year-over-year, Weighted Average Shares Outstanding (Diluted) has increased for 20 consecutive quarters, with growth averaging 16.9% over the last eight quarters.
- Across the past five years, year-over-year growth in Weighted Average Shares Outstanding (Diluted) ran from 7.1% in Q3 2023 to 197.7% in Q1 2022.
- Business Quant data shows KYMR's Weighted Average Shares Outstanding (Diluted) at 98.18 million (Q2 2026), 97.53 million (Q1 2026) and 84.49 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 893.40 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.45 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 1.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.48 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 1.96 Bn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 1.56 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 546.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.25 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.75 Bn |
| 10 | Kymera Therapeutics | 11.66 Bn | 8.50 Bn | - | 100.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 100.10 Mn |
| Jun 30, 2026 | 98.18 Mn |
| Mar 31, 2026 | 97.53 Mn |
| Dec 31, 2025 | 84.49 Mn |
| Sep 30, 2025 | 87.30 Mn |
| Jun 30, 2025 | 80.45 Mn |
| Mar 31, 2025 | 80.15 Mn |
| Dec 31, 2024 | 75.04 Mn |
| Sep 30, 2024 | 76.13 Mn |
| Jun 30, 2024 | 73.06 Mn |
| Mar 31, 2024 | 70.77 Mn |
| Dec 31, 2023 | 58.37 Mn |
| Sep 30, 2023 | 58.42 Mn |
| Jun 30, 2023 | 58.33 Mn |
| Mar 31, 2023 | 58.19 Mn |
| Dec 31, 2022 | 53.93 Mn |
| Sep 30, 2022 | 54.54 Mn |
| Jun 30, 2022 | 51.77 Mn |
| Mar 31, 2022 | 51.65 Mn |
| Dec 31, 2021 | 47.99 Mn |
API Access
Kymera Therapeutics Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=KYMR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "KYMR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=KYMR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();